Achieve Life Sciences grants CFO 200,000 options

The option award has a $7.01 exercise price and expires October 5, 2036; both awards vest over time subject to service.

Rhea-AI Filing Summary

Achieve Life Sciences, Inc. Chief Financial Officer Benjamin Halladay was granted two equity awards on October 5, 2026: stock options covering 200,000 common shares, with a $7.01 exercise price and an expiration date of October 5, 2036, and 200,000 restricted stock units (RSUs). Each RSU represents a contingent right to receive one common share at settlement. The options vest as to 1/4 of the award on the first anniversary and in substantially equal monthly installments over the following 36 months. The RSUs vest as to 1/4 of the award on each of October 5, 2027, October 5, 2028, October 5, 2029, and October 5, 2030. Both awards are subject to Halladay providing service on each vesting date.

Insider Trade Summary

Grant/Award: 400,000 shares

Grant/Award 2 txns

Insider Halladay Benjamin

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy) F1	200,000	$0.00	$0.00
Grant/Award	Restricted Stock Unit (RSU) F2, F3	200,000	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy) — 200,000 contracts (Direct); Restricted Stock Unit (RSU) — 200,000 contracts (Direct)

Footnotes (3)

1. F1. This option will vest as to 1/4 of the total award on the first anniversary of October 5, 2026, and thereafter in substantially equal monthly installments over 36 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
2. F2. Each RSU represents a contingent right to receive one share of the issuer's common stock at settlement.
3. F3. The RSUs will vest as to 1/4 of the total award on each of October 5, 2027, October 5, 2028, October 5, 2029 and October 5, 2030 subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Key Figures

Stock options granted: 200,000 options Option exercise price: $7.01 per share Option expiration date: October 5, 2036 +3 more

6 metrics

Stock options granted 200,000 options Granted October 5, 2026; options cover common shares

Option exercise price $7.01 per share Stock option award granted October 5, 2026

Option expiration date October 5, 2036 Stock option award

Restricted stock units granted 200,000 RSUs Granted October 5, 2026; each RSU represents a contingent right to receive one common share at settlement

Option vesting schedule 1/4 on the first anniversary; substantially equal monthly installments over 36 months thereafter Subject to service on each vesting date

RSU vesting dates October 5, 2027; October 5, 2028; October 5, 2029; October 5, 2030 1/4 of the award vests on each date, subject to service

Key Terms

Stock Option (right to buy), Restricted Stock Unit (RSU), contingent right, vest

4 terms

Stock Option (right to buy) financial

"Stock Option (right to buy)"

Restricted Stock Unit (RSU) financial

"Each RSU represents a contingent right"

A restricted stock unit (RSU) is a promise from a company to give an employee company shares (or cash equal to their value) at a future date if certain conditions are met, such as staying with the company or hitting performance targets. For investors, RSUs matter because when they convert into actual shares they increase the number of shares available and can create selling pressure as employees cash out—think of them as a future paycheck paid in company stock.

contingent right financial

"a contingent right to receive one share"

vest financial

"will vest as to 1/4 of the total award"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did Benjamin Halladay receive from ACHV?

Chief Financial Officer Benjamin Halladay was granted stock options covering 200,000 common shares and 200,000 RSUs on October 5, 2026. Each RSU is a contingent right to receive one common share at settlement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/06/2026 - 04:15 PM Accepted by SEC EDGAR 10/06/2026 - 04:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Halladay Benjamin

(Last) (First) (Middle)

C/O ACHIEVE LIFE SCIENCES, INC.

22722 29TH DR. SE, SUITE 100

(Street)

BOTHELL WASHINGTON 98021

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ACHIEVE LIFE SCIENCES, INC. [ ACHV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$7.01	10/05/2026		A		200,000		(1)	10/05/2036	Common Stock	200,000	$0	200,000	D
Restricted Stock Unit (RSU)	(2)	10/05/2026		A		200,000		(3)	10/05/2030	Common Stock	200,000	$0	200,000	D

Explanation of Responses:

1. This option will vest as to 1/4 of the total award on the first anniversary of October 5, 2026, and thereafter in substantially equal monthly installments over 36 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

2. Each RSU represents a contingent right to receive one share of the issuer's common stock at settlement.

3. The RSUs will vest as to 1/4 of the total award on each of October 5, 2027, October 5, 2028, October 5, 2029 and October 5, 2030 subject to the Reporting Person's provision of service to the Issuer on each vesting date.

	/s/ Erik Atkisson as attorney-in-fact	10/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)